We are live on ! Find out more
CCM

Covington Capital Management Portfolio holdings

AUM $2.32B
1-Year Est. Return 12.18%
This Fund
S&P 500
This Quarter Est. Return
-13.4%
1 Year Est. Return
-12.18%
3 Year Est. Return
+32.05%
5 Year Est. Return
+64.04%
10 Year Est. Return
AUM
$2.46B
AUM Growth
-$327M
Cap. Flow
+$82.2M
Cap. Flow %
3.34%
Top 10 Hldgs %
24.25%
Holding
1,232
New
119
Increased
264
Reduced
303
Closed
152

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$43.7M
2
HALO icon
Halozyme
HALO
+$10.7M
3
CSCO icon
Cisco
CSCO
+$7.6M
4
PFE icon
Pfizer
PFE
+$4.73M
5
HD icon
Home Depot
HD
+$4.53M

Sector Composition

Rank Sector Weight
1 Technology 20.65%
2 Healthcare 12.56%
3 Financials 9.39%
4 Consumer Discretionary 7.83%
5 Consumer Staples 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVAX
726
DELISTED
Dynavax Technologies
DVAX
$17K ﹤0.01%
1,350
ED icon
727
Consolidated Edison
ED
$40.1B
$17K ﹤0.01%
175
+25
+17% +$2.38K
JBLU icon
728
JetBlue
JBLU
$2.28B
$17K ﹤0.01%
2,000
KRBN icon
729
KraneShares Global Carbon Strategy ETF
KRBN
$140M
$17K ﹤0.01%
350
SNA icon
730
Snap-on
SNA
$21.2B
$17K ﹤0.01%
87
-2
-2% -$426
SUN icon
731
Sunoco
SUN
$14.4B
$17K ﹤0.01%
450
TEVA icon
732
Teva Pharmaceuticals
TEVA
$40.8B
$17K ﹤0.01%
2,275
TTD icon
733
Trade Desk
TTD
$8.48B
$17K ﹤0.01%
400
VRSN icon
734
VeriSign
VRSN
$26.2B
$17K ﹤0.01%
100
SMAR
735
DELISTED
Smartsheet Inc.
SMAR
$17K ﹤0.01%
550
Y
736
DELISTED
Alleghany Corp
Y
$17K ﹤0.01%
20
-23
-53% -$19.2K
BGR icon
737
BlackRock Energy and Resources Trust
BGR
$421M
$16K ﹤0.01%
+1,500
New +$17.9K
BJAN icon
738
Innovator US Equity Buffer ETF January
BJAN
$345M
$16K ﹤0.01%
500
CHKP icon
739
Check Point Software Technologies
CHKP
$13B
$16K ﹤0.01%
130
DGX icon
740
Quest Diagnostics
DGX
$25.7B
$16K ﹤0.01%
119
+19
+19% +$2.59K
FLGT icon
741
Fulgent Genetics
FLGT
$470M
$16K ﹤0.01%
300
FMC icon
742
FMC
FMC
$1.34B
$16K ﹤0.01%
+146
New +$17.8K
FNF icon
743
Fidelity National Financial
FNF
$13.9B
$16K ﹤0.01%
444
LVS icon
744
Las Vegas Sands
LVS
$31.7B
$16K ﹤0.01%
480
PXH icon
745
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.94B
$16K ﹤0.01%
+874
New +$17K
RGR icon
746
Sturm, Ruger & Co
RGR
$594M
$16K ﹤0.01%
250
TOL icon
747
Toll Brothers
TOL
$13.6B
$16K ﹤0.01%
366
-15,649
-98% -$732K
WAB icon
748
Wabtec
WAB
$49.1B
$16K ﹤0.01%
198
+33
+20% +$2.94K
BAUG icon
749
Innovator US Equity Buffer ETF August
BAUG
$199M
$15K ﹤0.01%
500
BE icon
750
Bloom Energy
BE
$60.6B
$15K ﹤0.01%
900

Similar funds

Covington Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Covington Capital Management held 1,232 positions worth $2.46B, down 12% from $2.79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Covington Capital Management deployed $82.2M of net new capital in Q2 2022, opening 119 new positions and adding to 264 existing holdings. Its largest new stake was Halozyme: 247,500 shares worth $10.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund, an estimated $6.8M trimmed.

  • Covington Capital Management's largest Q2 2022 buy was Halozyme: 247,500 shares worth $10.9M.
  • Covington Capital Management added most to Microsoft in Q2 2022, an estimated $43.7M increase.
  • Covington Capital Management's biggest Q2 2022 reduction was PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund, cutting an estimated $6.8M.
  • Covington Capital Management fully exited MGM Growth Properties LLC Class A common shares representing limited liability company interests in Q2 2022, selling an estimated $1.82M.
  • Covington Capital Management's ten largest holdings make up 24% of its $2.46B portfolio in Q2 2022.
  • Covington Capital Management opened 119 new positions and closed 152 in Q2 2022.
  • Covington Capital Management's portfolio value fell 12% quarter-over-quarter to $2.46B.

Based on Covington Capital Management's 13F filing for Q2 2022, filed 8 Jul 2022.